Kennedy Capital Management, Inc. Zymeworks Inc. Transaction History

Kennedy Capital Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$4.82 - $7.7 $496,831 - $793,692	-103,077 Reduced 72.1%	39,891 $211,000
Q1 2022 May 16, 2022	SELL	$6.0 - $16.98 $342,420 - $969,048	-57,070 Reduced 28.53%	142,968 $936,000
Q4 2021 Feb 14, 2022	BUY	$15.19 - $29.33 $2.48 Million - $4.8 Million	163,571 Added 448.55%	200,038 $3.28 Million
Q3 2021 Nov 15, 2021	BUY	$27.35 - $37.28 $997,372 - $1.36 Million	36,467 New	36,467 $1.06 Million

296K

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $872M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Kennedy Capital Management, Inc. with notifications on news.